Tumor suppressor miR-375 regulates MYC expression via repression of CIP2A coding sequence through multiple miRNA-mRNA interactions

Molecular Biology of the Cell

Volumn 24, Issue 11, 2013, Pages 1638-1648

  Jung, Hyun Min ^a   Patel, Rushi S ^a   Phillips, Brittany L ^a   Wang, Hai ^a   Cohen, Donald M ^a   Reinhold, William C ^a   Chang, Lung Ji ^b   Yang, Li Jun ^a   Chan, Edward K L ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCEROUS INHIBITOR OF PP2A PROTEIN; MESSENGER RNA; MICRORNA 375; MYC PROTEIN; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROTEIN; TUBULIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CELL MIGRATION; CONTROLLED STUDY; GENE SEQUENCE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MOUTH CANCER; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR INVASION; WESTERN BLOTTING;

AUTOANTIGENS; BASE SEQUENCE; BINDING SITES; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; LUCIFERASES; MEMBRANE PROTEINS; MICRORNAS; MOLECULAR SEQUENCE DATA; MOUTH NEOPLASMS; MUTATION; OPEN READING FRAMES; PRIMARY CELL CULTURE; PROTO-ONCOGENE PROTEINS C-MYC; RNA, MESSENGER; SIGNAL TRANSDUCTION; TONGUE;

EID: 84878682019     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E12-12-0891     Document Type: Article

References (71)

1. Abdelmohsen K et al. (2010). miR-375 inhibits differentiation of neurites by lowering HuD levels. Mol Cell Biol 30, 4197-4210.
2. Ambros V (2004). The functions of animal microRNAs. Nature 431, 350-355. (Pubitemid 39265675)
3. Avissar M, Christensen BC, Kelsey KT, Marsit CJ (2009). MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma. Clin Cancer Res 15, 2850-2855.
4. Baek D, Villen J, Shin C, Camargo FD, Gygi SP, Bartel DP (2008). The impact of microRNAs on protein output. Nature 455, 64-71.
5. Bartel DP (2009). MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233.
6. Come C et al. (2009). CIP2A is associated with human breast cancer aggressivity. Clin Cancer Res 15, 5092-5100.
7. Dang CV (2012). MYC on the path to cancer. Cell 149, 22-35.
8. Ding L et al. (2010). MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2. Cell Res 20, 784-793.
9. Dong QZ, Wang Y, Dong XJ, Li ZX, Tang ZP, Cui QZ, Wang EH (2011). CIP2A is overexpressed in non-small cell lung cancer and correlates with poor prognosis. Ann Surg Oncol 18, 857-865.
10. Duursma AM, Kedde M, Schrier M, le Sage C, Agami R (2008). miR-148 targets human DNMT3b protein coding region. RNA 14, 872-877. (Pubitemid 351574909)
11. Enright AJ, John B, Gaul U, Tuschl T, Sander C, Marks DS (2003). MicroRNA targets in Drosophila. Genome Biol 5, R1.
12. Esquela-Kerscher A, Slack FJ (2006). Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 6, 259-269.
13. Fang Z, Rajewsky N (2011). The impact of miRNA target sites in coding sequences and in 3'UTRs. PLoS One 6, e18067.
14. Fernandez PC, Frank SR, Wang L, Schroeder M, Liu S, Greene J, Cocito A, Amati B (2003). Genomic targets of the human c-Myc protein. Genes Dev 17, 1115-1129. (Pubitemid 36534986)
15. Forman JJ, Legesse-Miller A, Coller HA (2008). A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence. Proc Natl Acad Sci USA 105, 14879-14884.
16. Friedman RC, Farh KK, Burge CB, Bartel DP (2009). Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19, 92-105.
17. Funk GF, Karnell LH, Robinson RA, Zhen WK, Trask DK, Hoffman HT (2002). Presentation, treatment, and outcome of oral cavity cancer: a National Cancer Data Base report. Head Neck 24, 165-180. (Pubitemid 34111514)
18. Garzon R, Marcucci G, Croce CM (2010). Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov 9, 775-789.
19. Harris T et al. (2012). Low-level expression of miR-375 correlates with poor outcome and metastasis while altering the invasive properties of head and neck squamous cell carcinomas. Am J Pathol 180, 917-928.
20. Howlader N et al. (2012). SEER Cancer Statistics Review, 1975-2009. Available at: http://seer.cancer.gov/csr/1975-2009-pops09/index.html (accessed 2012)
21. Hui AB et al. (2011). Significance of dysregulated metadherin and microRNA-375 in head and neck cancer. Clin Cancer Res 17, 7539-7550.
22. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011). Global cancer statistics. CA Cancer J Clin 61, 69-90.
23. Johnson SM et al. (2005). RAS is regulated by the let-7 microRNA family. Cell 120, 635-647. (Pubitemid 40343076)
24. Jung HM, Phillips BL, Patel RS, Cohen DM, Jakymiw A, Kong WW, Cheng JQ, Chan EK (2012). Keratinization-associated miR-7 and miR-21 regulate tumor suppressor reversion-inducing-cysteine-rich protein with kazal motifs (RECK) in oral cancer. J Biol Chem 287, 29261-29272.
25. Junttila MR et al. (2007). CIP2A inhibits PP2A in human malignancies. Cell 130, 51-62. (Pubitemid 47039258)
26. Junttila MR, Westermarck J (2008). Mechanisms of MYC stabilization in human malignancies. Cell Cycle 7, 592-596. (Pubitemid 351498996)
27. Katz J, Jakymiw A, Ducksworth MK, Stewart CM, Bhattacharyya I, Cha S, Chan EK (2010). CIP2A expression and localization in oral carcinoma and dysplasia. Cancer Biol Ther 10, 694-699.
28. Kloosterman WP, Wienholds E, Ketting RF, Plasterk RH (2004). Substrate requirements for let-7 function in the developing zebrafish embryo. Nucleic Acids Res 32, 6284-6291. (Pubitemid 40202087)
29. Kong KL, Kwong DL, Chan TH, Law SY, Chen L, Li Y, Qin YR, Guan XY (2012). MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor. Gut 61, 33-42.
30. Krek A et al. (2005). Combinatorial microRNA target predictions. Nat Genet 37, 495-500. (Pubitemid 40617277)
31. Kumar MS, Erkeland SJ, Pester RE, Chen CY, Ebert MS, Sharp PA, Jacks T (2008). Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc Natl Acad Sci USA 105, 3903-3908. (Pubitemid 351723497)
32. Ladeiro Y, Couchy G, Balabaud C, Bioulac-Sage P, Pelletier L, Rebouissou S, Zucman-Rossi J (2008). MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology 47, 1955-1963. (Pubitemid 351952843)
33. Lee GY, Kenny PA, Lee EH, Bissell MJ (2007). Three-dimensional culture models of normal and malignant breast epithelial cells. Nat Methods 4, 359-365. (Pubitemid 46766981)
34. Lewis BP, Burge CB, Bartel DP (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20. (Pubitemid 40094598)
35. Li W, Ge Z, Liu C, Liu Z, Bjorkholm M, Jia J, Xu D (2008). CIP2A is overexpressed in gastric cancer and its depletion leads to impaired clonogenicity, senescence, or differentiation of tumor cells. Clin Cancer Res 14, 3722-3728.
36. Liang CC, Park AY, Guan JL (2007). In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2, 329-333. (Pubitemid 47040047)
37. Lippman SM, Sudbo J, Hong WK (2005). Oral cancer prevention and the evolution of molecular-targeted drug development. J Clin Oncol 23, 346-356. (Pubitemid 46206883)
38. Llave C, Xie Z, Kasschau KD, Carrington JC (2002). Cleavage of Scarecrow-like mRNA targets directed by a class of Arabidopsis miRNA. Science 297, 2053-2056.
39. Lu J et al. (2005). MicroRNA expression profiles classify human cancers. Nature 435, 834-838. (Pubitemid 40839735)
40. Lytle JR, Yario TA, Steitz JA (2007). Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5' UTR as in the 3' UTR. Proc Natl Acad Sci USA 104, 9667-9672. (Pubitemid 47175324)
41. Messadi DV, Wilder-Smith P, Wolinsky L (2009). Improving oral cancer survival: the role of dental providers. J Calif Dent Assoc 37, 789-798.
42. Miranda KC, Huynh T, Tay Y, Ang YS, Tam WL, Thomson AM, Lim B, Rigoutsos I (2006). A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell 126, 1203-1217. (Pubitemid 44380294)
43. Nelson PT, Wang WX, Mao G, Wilfred BR, Xie K, Jennings MH, Gao Z, Wang X (2011). Specific sequence determinants of miR-15/107 microRNA gene group targets. Nucleic Acids Res 39, 8163-8172.
44. Nohata N et al. (2011). Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC). J Hum Genet 56, 595-601.
45. Ott CE et al. (2011). MicroRNAs differentially expressed in postnatal aortic development downregulate elastin via 3' UTR and coding-sequence binding sites. PLoS One 6, e16250.
46. Pan W et al. (2010). MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. J Immunol 184, 6773-6781.
47. Pfaffl MW (2001). A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29, e45.
48. Prochownik EV (2008). c-Myc: linking transformation and genomic instability. Curr Mol Med 8, 446-458.
49. Reczko M, Maragkakis M, Alexiou P, Grosse I, Hatzigeorgiou AG (2012). Functional microRNA targets in protein coding sequences. Bioinformatics 28, 771-776.
50. Reinhold WC, Sunshine M, Liu H, Varma S, Kohn KW, Morris J, Doroshow J, Pommier Y (2012). CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set. Cancer Res 72, 3499-3511.
51. Ren J et al. (2011). Expression of CIP2A in renal cell carcinomas correlates with tumour invasion, metastasis and patients' survival. Br J Cancer 105, 1905-1911.
52. Rhoades MW, Reinhart BJ, Lim LP, Burge CB, Bartel B, Bartel DP (2002). Prediction of plant microRNA targets. Cell 110, 513-520. (Pubitemid 35232294)
53. Saetrom P, Heale BS, Snove O Jr, Aagaard L, Alluin J, Rossi JJ (2007). Distance constraints between microRNA target sites dictate efficacy and cooperativity. Nucleic Acids Res 35, 2333-2342. (Pubitemid 47073716)
54. Seike M et al. (2009). MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers. Proc Natl Acad Sci USA 106, 12085-12090.
55. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N (2008). Widespread changes in protein synthesis induced by microRNAs. Nature 455, 58-63.
56. Shi FD et al. (2005). Preferential humoral immune response in prostate cancer to cellular proteins p90 and p62 in a panel of tumor-associated antigens. Prostate 63, 252-258.
57. Shiboski CH, Shiboski SC, Silverman S Jr (2000). Trends in oral cancer rates in the United States, 1973-1996. Community Dent Oral Epidemiol 28, 249-256.
58. Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY (2007). miR-21-mediated tumor growth. Oncogene 26, 2799-2803. (Pubitemid 46663837)
59. Soo Hoo L, Zhang JY, Chan EK (2002). Cloning and characterization of a novel 90 kDa 'companion' auto-antigen of p62 overexpressed in cancer. Oncogene 21, 5006-5015.
60. Sun W, Julie Li YS, Huang HD, Shyy JY, Chien S (2010). microRNA: a master regulator of cellular processes for bioengineering systems. Annu Rev Biomed Eng 12, 1-27.
61. Tay Y, Zhang J, Thomson AM, Lim B, Rigoutsos I (2008). MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 455, 1124-1128.
62. Tazawa H, Tsuchiya N, Izumiya M, Nakagama H (2007). Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci USA 104, 15472-15477. (Pubitemid 47502941)
63. Tsukamoto Y et al. (2010). MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. Cancer Res 70, 2339-2349.
64. van der Waal I, de Bree R, Brakenhoff R, Coebergh JW (2011). Early diagnosis in primary oral cancer: is it possible? Med Oral Patol Oral Cir Bucal 16, e300-e305.
65. Vella MC, Choi EY, Lin SY, Reinert K, Slack FJ (2004). The C. elegans microRNA let-7 binds to imperfect let-7 complementary sites from the lin-41 3'UTR. Genes Dev 18, 132-137. (Pubitemid 38141781)
66. Volinia S et al. (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103, 2257-2261. (Pubitemid 43271657)
67. Voorhoeve PM, Agami R (2007). Classifying microRNAs in cancer: the good, the bad and the ugly. Biochim Biophys Acta 1775, 274-282. (Pubitemid 46899338)
68. Wang F et al. (2011). miR-375 is down-regulated in squamous cervical cancer and inhibits cell migration and invasion via targeting transcription factor SP1. Am J Pathol 179, 2580-2588.
69. Yamakuchi M, Ferlito M, Lowenstein CJ (2008). miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci USA 105, 13421-13426.
70. Yang JH, Li JH, Shao P, Zhou H, Chen YQ, Qu LH (2011). starBase: a database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data. Nucleic Acids Res 39, D202-D209.
71. Zhou X, Duan X, Qian J, Li F (2009). Abundant conserved microRNA target sites in the 5'-untranslated region and coding sequence. Genetica 137, 159-164.